Drug Profile
P 7
Alternative Names: P-7; Peptide P-7Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Unknown
- Developer 13therapeutics
- Class Anti-inflammatories; Peptides
- Mechanism of Action Toll-like receptor 3 antagonists; Toll-like receptor 4 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Inflammation in USA
- 20 Jul 2016 Early research in Inflammation in USA (unspecified route)